Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J's Stelara effective in psoriatic arthritis trial
Reuters
Tuesday, June 11, 2013 - 10:45pm
tags:
JNJ, Stelara, psoriatic arthritis
Blue Belt touts FDA win for Stride knee implant
Mass Device
Tuesday, June 11, 2013 - 10:44pm
tags:
Blue Belt, FDA, knee, implants, devices
Histogenics appoints a new CEO | Personnel Moves
Mass Device
Tuesday, June 11, 2013 - 10:43pm
tags:
Histogenics, CEO, Management, devices
Vision: WaveTec raises $11M for cataract surgery tech
Mass Device
Tuesday, June 11, 2013 - 10:42pm
tags:
WaveTec, surgical, devices, funding
GE Healthcare launches $2B software-development program
Mass Device
Tuesday, June 11, 2013 - 10:42pm
tags:
GE Healthcare, devices, software, technology, development
CryoLife lands another win for its HeRo line
Mass Device
Tuesday, June 11, 2013 - 10:41pm
tags:
Cryolife, HeRo, devices
TVA Medical grabs $9.5M to test kidney-failure treatment device
FierceMedicalDevice
Tuesday, June 11, 2013 - 10:35pm
tags:
TVA Medical, kidney, treatment, devices
Cook's Zilver stent recall could be a costly one
FierceMedicalDevice
Tuesday, June 11, 2013 - 10:34pm
tags:
Cook Medical, stent, Zilver, recall, devices, regulatory
Why Techne May Be About to Take Off
The Motley Fool
Tuesday, June 11, 2013 - 10:30pm
tags:
Techne, stock, devices
Exactech Introduces Conservative Treatment Hip Replacement System
Yahoo/BusinessWire
Tuesday, June 11, 2013 - 10:30pm
tags:
Exatech, treatment, devices, hip replacements
SpectraScience, Inc. Announces Positive Results From Study by Dr. Helmut Neumann
Yahoo/MarketWired
Tuesday, June 11, 2013 - 10:29pm
tags:
SpectraScience, devices, study
Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold
Yahoo/PRNewswire
Tuesday, June 11, 2013 - 10:28pm
tags:
Abbott, clinical trials, Japan, international, devices
GenMark down 7% after Natural Molecular launches new product
The Fly On The Wall
Tuesday, June 11, 2013 - 10:20pm
tags:
GenMark, devices, Natural Molecular, launch
MiMedx Is Issued Three New U.S. Patents For Placental Tissue Allografts
Yahoo/PRNewswire
Tuesday, June 11, 2013 - 9:58pm
tags:
MiMedx, patents, devices
St. Jude Medical Announces FDA Approval of High-Voltage Devices with New Safety Features
Yahoo/BusinessWire
Tuesday, June 11, 2013 - 9:58pm
tags:
St. Jude Medical, FDA, devices, regulatory, safety
MD Anderson Signs Contract For Pyxis ES Technology From CareFusion
Yahoo/PRNewswire
Tuesday, June 11, 2013 - 9:55pm
tags:
CareFusion, Pyxis, cancer, devices
Symmetry Provides Dismal 2013 View
Yahoo/Zacks
Tuesday, June 11, 2013 - 9:26pm
tags:
Symmetry Medical, earnings, devices
Hill-Rom Launches New Hospital Hand Hygiene Monitoring Solution
Yahoo/PRNewswire
Tuesday, June 11, 2013 - 9:25pm
tags:
Hill-Rom, Hospital, devices, monitoring
NovaBay: Upcoming Auriclosene Data Could Be A Catalyst
Seeking Alpha
Tuesday, June 11, 2013 - 5:02pm
tags:
auriclosene, NovaBay
Salix, Progenics shares rise after FDA panel says it will review constipation drug Relistor
Yahoo/AP
Tuesday, June 11, 2013 - 5:00pm
tags:
FDA, Salix, Progenics, advisory panels, constipation, Relistor

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.